NCT02151695View on ClinicalTrials.gov

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

March 6, 2020

Conditions
Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy
Interventions
PROCEDURE

panretinal photocoagulation

DRUG

Aflibercept intravitreal injections

Trial Locations (1)

Unknown

Chu de Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT02151695 - Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy. | Biotech Hunter | Biotech Hunter